Intravenous Methylene Blue as a Rescue Therapy in the Management of Refractory Hypoxia in COVID-19 ARDS Patients: A Case Series

Objectives: To describe the clinical outcomes of hypoxic coronavirus disease 2019 (COVID-19) patients treated with intravenous methylene blue (MB) in a tertiary care hospital. Materials and methods: We conducted a case series of 50 patients with hypoxic COVID-19 treated with intravenous MB admitted...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahale, Nilesh, Godavarthy, Purushotham, Marreddy, Srinath, Gokhale, Snehal D, Funde, Pradip, Rajhans, Prasad A, Akole, Prasad V, Pawar, Balasaheb, Bhurke, Bhagyashri, Dalvi, Pradip, Marudwar, Prasanna, Gugale, Shradha, Shahane, Manasi S, Kshirsagar, Sarang N, Jog, Sameer A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559741/
https://www.ncbi.nlm.nih.gov/pubmed/34733037
http://dx.doi.org/10.5005/jp-journals-10071-23905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559741/
https://www.ncbi.nlm.nih.gov/pubmed/34733037
http://dx.doi.org/10.5005/jp-journals-10071-23905

Ejemplares similares